Similarly, Grote and colleagues [76] developed a second-generation B7-H3 CAR-NK-92 cell line, which showed high specificity by lysing neuroblastoma cells expressing high B7-H3 levels while sparing B7-H3-negative cell populations. This evidence concerns the gene CD276 and neuroblastoma.